GE Healthcare has announced that researchers, using the company's existing technology Computed Tomography (CT) platform, have developed a method to acquire volume dual energy images for the first time. The method is currently under investigation at Keio University in Japan, where the first clinical images were captured by Dr. Sachio Kuribayashi, Chairman and Professor of Radiology, on his LightSpeed VCT.

According to Gene Saragnese, Global Vice President of Molecular Imaging & CT at GE Healthcare, this latest technological innovation has the future potential to enable an existing system to capture dual energy images. "This approach, utilizing a unique acquisition protocol useable to the full 50cm field of view, may help clinicians expand clinical capabilities with new applications that could include material decomposition (e.g. separation of iodine and calcium) and simplifying bone vessel segmentation," said Saragnese.

By building on the foundation of GE's advanced CT platform, potential future clinical implementation of this research method may allow existing users to expand the clinical utility of volume CT.

GE will discuss this innovative CT research project, among others, at the 8th Annual International Symposium on Multidetector-Row CT, sponsored by Stanford Radiology. Dr. Kuribayashi will present the first clinical images at this event.
\tAbout GE Healthcare
\t

GE Healthcare provides transformational medical technologies that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform and treat disease, so their patients can live their lives to the fullest.

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases, and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention.

More Industry Headlines